Accelerometry as a measure of walking behavior in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 127, Issue 6, 2013, Pages 384-390

  Motl, R W ^a   Pilutti, L ^a   Sandroff, B M ^a   Dlugonski, D ^a   Sosnoff, J J ^a   Pula, J H ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Ambulation; Mobility; Multiple sclerosis; Neurology; Walking

Indexed keywords

6 MINUTE WALK TEST; ACCELEROMETER; ACCELEROMETRY; ADULT; ARTICLE; EXERCISE TEST; EXPANDED DISABILITY STATUS SCALE; FEMALE; GAIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS WALKING SCALE 12; OXYGEN CONSUMPTION; PATIENT DETERMINED DISEASE STEPS SCALE; RATING SCALE; SCORING SYSTEM; TIME 25 FOOT WALK TEST; VALIDITY; VELOCITY; WALKING;

ACCELEROMETRY; ADULT; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; GAIT; HUMANS; MALE; MIDDLE AGED; MOBILITY LIMITATION; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; WALKING;

EID: 84877921839     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12036     Document Type: Article

References (30)

1. Goldman MD, Motl RW, Rudick RA. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord 2010;3:229-39.
2. LaRocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient 2001;4:189-201.
3. Pearson OR, Busse ME, Van Deursen RWM, Wiles CM. Quantification of walking mobility in neurological disorders. Q J Med 2004;97:463-75.
4. Cavanaugh JT, Gappmaier VO, Dibble LE et al. Ambulatory activity in individuals with multiple sclerosis. J Neurol Phys Ther 2011;35:26-33.
5. Gijbels D, Alders G, Van Hoof E et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler 2010;16:618-26.
6. Weikert M, Suh Y, Lane A et al. Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis. Med Eng Phys 2012;34:590-7.
7. Hale LA, Pal J, Becker I. Measuring free-living physical activity in adults with and without neurologic dysfunction with a triaxial accelerometer. Arch Phys Med Rehabil 2008;89:1765-71.
8. Klassen L, Schachter C, Scudds R. An exploratory study of two measures of free-living physical activity for people with multiple sclerosis. Clin Rehabil 2008;22:260-71.
9. Motl RW, Dlugonski D, Suh Y et al. Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis. Arch Phys Med Rehabil 2010;91:1942-7.
10. ™ technology. Gait Posture 2011;34:145-7.
11. Sosnoff JJ, Goldman MD, Motl RW. Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data. Mult Scler 2010;16:868-77.
12. Sosnoff JJ, Socie MJ, Boes MK et al. Ambulatory mobility monitoring in people with multiple sclerosis. J Rehabil Res Dev, in press.
13. Hadjimichael O, Kerns RB, Rizzo MA et al. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 2007;127:35-41.
14. Hobart JC, Riazi A, Lampin DL et al. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale. Neurology 2003;60:31-6.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
16. Fisher JS, Jak AJ, Kniker JE et al. Multiple sclerosis functional composite (MSFC): administration and scoring manual, 2001;1-44.
17. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008;14:383-90.
18. Motl RW, Suh Y, Dlugonski D et al. Oxygen cost of treadmill and over-ground walking in mildly disabled persons with multiple sclerosis. Neurol Sci 2011;32:255-62.
19. Sosnoff JJ, Sandroff B, Motl RW. Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability. Gait Posture 2012;36:154-6.
20. Motl RW, Snook EM, Agiovlasitas S. Does an accelerometer accurately measure steps taken under controlled conditions in adults with mild multiple sclerosis? Disabil Health J 2011;4:52-7.
21. Motl RW, Sandroff BM. Objective monitoring of physical activity behavior in multiple sclerosis. Phys Ther Rev 2010;15:204-11.
22. Motl RW, Zhu W, Park Y, McAuley E, Scott JA, Snook EM. Reliability of scores from physical activity monitors in adults with multiple sclerosis. Adapt Phys Activ Q 2007;24:245-53.
23. Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
24. Confavreux C, Vukusic S. Age at disability milestone in multiple sclerosis. Brain 2006;129(Pt 3):595-605.
25. Lord SE, Rochester L. Measurement of community ambulation after stroke: current status and future developments. Stroke 2005;36:1457-61.
26. Fulk GD, Reynolds C, Mondal S, Deutsch JE. Predicting home and community walking activity in people with stroke. Arch Phys Med Rehabil 2010;91:1582-6.
27. Rand D, Eng JJ, Tang PF, Jeng JS, Hung C. How active are people with stroke?: use of accelerometers to assess physical activity. Stroke 2009;40:163-8.
28. Schmidt AL, Pennypacker ML, Thrush AH, Leiper CI, Craik RL. Validity of the StepWatch Step Activity Monitor: preliminary findings for use in persons with Parkinson disease and multiple sclerosis. J Geriatr Phys Ther 2011;34:41-5.
29. Motl RW, McAuley E. Pathways between physical activity and quality of life in adults with multiple sclerosis. Health Psychol 2009;28:682-9.
30. Costelloe L, O'Rourke K, Kearney H et al. The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). J Neurol Neurosurg Psychiatry 2007;78:841-4.